Ophthalmology - Eye Health Academy

17-32 of 62

Insights and Updates: New Data on Next-Generation Retinal Treatments
Insights and Updates: New Data on Next-Generation Retinal Treatments
CME/CE
Insights and Updates: New Data on Next-Generation Retinal Treatments
Durga Borkar, MD, MMCi; Veeral Sheth, MD, MBA, FASRS, FACS
0.50 credits
- Durga Borkar, MD, MMCi
- Veeral Sheth, MD, MBA, FASRS, FACS
0.50 credits
Retina Case Review: Translating the Data Into Care
Retina Case Review: Translating the Data Into Care
CME/CE
Retina Case Review: Translating the Data Into Care
Durga Borkar, MD, MMCi; Veeral Sheth, MD, MBA, FASRS, FACS
0.25 credits
- Durga Borkar, MD, MMCi
- Veeral Sheth, MD, MBA, FASRS, FACS
0.25 credits
Presbyopia-Correcting Drops: The Importance of Patient Selection
Presbyopia-Correcting Drops: The Importance of Patient Selection
CME/CE
Presbyopia-Correcting Drops: The Importance of Patient Selection
Christina Y. Weng, MD, MBA, FASRS; Mohammad R. Rafieetary, OD, FAAO, FORS, ABO
0.25 credits
- Christina Y. Weng, MD, MBA, FASRS
- Mohammad R. Rafieetary, OD, FAAO, FORS, ABO
0.25 credits
The Role of Presbyopia-Correcting Drops
The Role of Presbyopia-Correcting Drops
CME/CE
The Role of Presbyopia-Correcting Drops
Mark T. Dunbar, OD, FAAO; David Eichenbaum, MD
0.25 credits
- Mark T. Dunbar, OD, FAAO
- David Eichenbaum, MD
0.25 credits
New Strategies for Individualizing Treatment in DME
New Strategies for Individualizing Treatment in DME
CME/CE
New Strategies for Individualizing Treatment in DME
Luis A. Gonzalez, MD, MPH; Jeremiah Brown Jr., MD, MS, FASRS
0.25 credits
- Luis A. Gonzalez, MD, MPH
- Jeremiah Brown Jr., MD, MS, FASRS
0.25 credits
From Doctor-Speak to Patient-Speak: Bridging the Communication Gap
From Doctor-Speak to Patient-Speak: Bridging the Communication Gap
CME/CE
From Doctor-Speak to Patient-Speak: Bridging the Communication Gap
Luis A. Gonzalez, MD, MPH; Jeremiah Brown Jr., MD, MS, FASRS
0.25 credits
- Luis A. Gonzalez, MD, MPH
- Jeremiah Brown Jr., MD, MS, FASRS
0.25 credits
Eye on the Target: Navigating Ocular Challenges With ADC Cancer Therapies
Eye on the Target: Navigating Ocular Challenges With ADC Cancer Therapies
CME/CE Broadcast Replay
Eye on the Target: Navigating Ocular Challenges With ADC Cancer Therapies
Kathleen N. Moore, MD, MS, FASCO; Aaron Samuel Gold, OD, FAAO
1.00 credit
- Kathleen N. Moore, MD, MS, FASCO
- Aaron Samuel Gold, OD, FAAO
- Carlo J. Pelino, OD, FAAO
1.00 credit
Antibody Drug Conjugates: Pretreatment Assessment and Ocular Toxicity Awareness
Antibody Drug Conjugates: Pretreatment Assessment and Ocular Toxicity Awareness
CME/CE
Antibody Drug Conjugates: Pretreatment Assessment and Ocular Toxicity Awareness
Kathleen N. Moore, MD, MS, FASCO; Kamran M. Riaz, MD
0.25 credits
- Kathleen N. Moore, MD, MS, FASCO
- Kamran M. Riaz, MD
0.25 credits
Understanding Antibody-Drug Conjugates (ADCs)
Understanding Antibody-Drug Conjugates (ADCs)
CME/CE
Understanding Antibody-Drug Conjugates (ADCs)
Aaron Samuel Gold, OD, FAAO; Carlo J. Pelino, OD, FAAO
0.25 credits
- Aaron Samuel Gold, OD, FAAO
- Carlo J. Pelino, OD, FAAO
0.25 credits
Collaborative Care: Managing ADC-Related Ocular Toxicities
Collaborative Care: Managing ADC-Related Ocular Toxicities
CME/CE
Collaborative Care: Managing ADC-Related Ocular Toxicities
Kathleen N. Moore, MD, MS, FASCO; Carlo J. Pelino, OD, FAAO
0.25 credits
- Kathleen N. Moore, MD, MS, FASCO
- Carlo J. Pelino, OD, FAAO
0.25 credits
Antibody Drug Conjugates: Insights and Challenges in Oncology and Ophthalmology
Antibody Drug Conjugates: Insights and Challenges in Oncology and Ophthalmology
CME/CE
Antibody Drug Conjugates: Insights and Challenges in Oncology and Ophthalmology
Aaron Samuel Gold, OD, FAAO; Timothy G. Murray, MD, MBA, FASRS
0.25 credits
- Aaron Samuel Gold, OD, FAAO
- Timothy G. Murray, MD, MBA, FASRS
0.25 credits
KOL KNOCKOUT^TM OCULOPLASTICS EDITION 8 Cases of Tailored Treatment for Thyroid Eye Disease
KOL KNOCKOUT^TM OCULOPLASTICS EDITION 8 Cases of Tailored Treatment for Thyroid Eye Disease
CME/CE
KOL KNOCKOUT^TM OCULOPLASTICS EDITION 8 Cases of Tailored Treatment for Thyroid Eye Disease
Andrew R. Harrison, MD; Kian Eftekhari, MD
1.00 credit
- Andrew R. Harrison, MD
- Kian Eftekhari, MD
- Andrew G. Lee, MD
- Wendy W. Lee, MD
- Nicholas Robert Mahoney, MD
- Amina Malik, MD
- Prem S. Subramanian, MD, PhD
- Jeremiah Tao, MD, FACS
1.00 credit
What’s New in Suprachoroidal MIGS?
What’s New in Suprachoroidal MIGS?
MinuteCE®
What’s New in Suprachoroidal MIGS?
I. Paul Singh, MD; Paul Petrakos, DO, MS
1.00 program credit
- I. Paul Singh, MD
- Paul Petrakos, DO, MS
1.00 program credit
What’s New With 3D Visualization in Glaucoma Surgery?
What’s New With 3D Visualization in Glaucoma Surgery?
MinuteCE®
What’s New With 3D Visualization in Glaucoma Surgery?
Paul Petrakos, DO, MS; I. Paul Singh, MD
1.00 program credit
- Paul Petrakos, DO, MS
- I. Paul Singh, MD
1.00 program credit
Evolving Strategies for Sustained-Release Glaucoma Treatments
Evolving Strategies for Sustained-Release Glaucoma Treatments
MinuteCE®
Evolving Strategies for Sustained-Release Glaucoma Treatments
Sarah H. Van Tassel, MD; Justin Schweitzer, OD, FAAO
1.00 program credit
- Sarah H. Van Tassel, MD
- Justin Schweitzer, OD, FAAO
1.00 program credit
Effective MIGS for Optimal IOP Control: A Case-Based Approach
Effective MIGS for Optimal IOP Control: A Case-Based Approach
MinuteCE®
Effective MIGS for Optimal IOP Control: A Case-Based Approach
Paul Petrakos, DO, MS; I. Paul Singh, MD
1.00 program credit
- Paul Petrakos, DO, MS
- I. Paul Singh, MD
1.00 program credit

2/4